Literature DB >> 26319952

Methylene blue, a potential therapeutic target for mitochondria dysfunction.

Xiang Lin1, Bing Bing Wu1, Qun Ya Xing1, Sheng Di Wang1, Jun Li2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26319952     DOI： 10.1016/j.intimp.2015.08.024

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN： 1567-5769            Impact factor:   4.932


× No keyword cloud information.
  2 in total

1.  Methylene Blue Protects Against Sevoflurane-Induced Cognitive Dysfunction by Suppressing Drp1 deSUMOylation in Aged Mice.

Authors:  Feng Zheng; Peng Fang; Jing Chang; Min Chen; Qi Zhong; Ting Chen; Chang Chen; Zongze Zhang
Journal:  Neurochem Res       Date:  2020-02-01       Impact factor: 3.996

2.  Methylene Blue Protects the Isolated Rat Lungs from Ischemia-Reperfusion Injury by Attenuating Mitochondrial Oxidative Damage.

Authors:  Wen-Fang Tian; Si Zeng; Qiong Sheng; Jun-Liang Chen; Ping Weng; Xiao-Tong Zhang; Jia-Jia Yuan; Qing-Feng Pang; Zhi-Qiang Wang
Journal:  Lung       Date:  2017-12-04       Impact factor: 2.584
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.